Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Impact of Morbid Obesity on the Outcomes of Type II Endometrial Cancer: a Cohort Study

Impact of Morbid Obesity on the Outcomes of Type II Endometrial Cancer: a Cohort Study Obesity has long been associated with endometrial cancer. However, there is a paucity of studies addressing the impact of morbid obesity in type II endometrial cancer on oncologic and surgical outcomes. In this study, the author retrospectively compared morbid to non-morbid obese in clinico-epidemiologic, surgical, and oncologic outcomes. Both groups were comparable as regards all clinico-epidemiologic parameters. Vaginal involvement, survival, and recurrence were also comparable between the 2 groups. Para-aortic adenopathy and treatment with preoperative therapy were the only significant predictors of DFS. Surgery is feasible with equivalent complications and oncologic outcomes in morbidly obese patients with type II endometrial cancer. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Indian Journal of Surgical Oncology Springer Journals

Impact of Morbid Obesity on the Outcomes of Type II Endometrial Cancer: a Cohort Study

Loading next page...
 
/lp/springer-journals/impact-of-morbid-obesity-on-the-outcomes-of-type-ii-endometrial-cancer-tQBoTW6Tvc
Publisher
Springer Journals
Copyright
Copyright © Indian Association of Surgical Oncology 2022
ISSN
0975-7651
eISSN
0976-6952
DOI
10.1007/s13193-022-01503-z
Publisher site
See Article on Publisher Site

Abstract

Obesity has long been associated with endometrial cancer. However, there is a paucity of studies addressing the impact of morbid obesity in type II endometrial cancer on oncologic and surgical outcomes. In this study, the author retrospectively compared morbid to non-morbid obese in clinico-epidemiologic, surgical, and oncologic outcomes. Both groups were comparable as regards all clinico-epidemiologic parameters. Vaginal involvement, survival, and recurrence were also comparable between the 2 groups. Para-aortic adenopathy and treatment with preoperative therapy were the only significant predictors of DFS. Surgery is feasible with equivalent complications and oncologic outcomes in morbidly obese patients with type II endometrial cancer.

Journal

Indian Journal of Surgical OncologySpringer Journals

Published: Sep 1, 2022

Keywords: Endometrial cancer; Hysterectomy; Obesity Non-endometrioid carcinoma

References